insurance coverage glp-1 news Health insurer Cigna will stop covering weight loss drugs in its employee health plan Medicaid Coverage of and Spending

Yes, clinical trials have shown that GLP-1 medications can lower cardiovascular risks among individuals with obesity and atherosclerotic vascular disease

Participants were randomly assigned 1:1 to once-weekly 1 mg semaglutide or placebo

Selective serotonin reuptake inhibitors and the risk of type 2 diabetes mellitus in youths

AMG133 represents a breakthrough conjugate treatment for type 2 diabetes, created to enhance patient convenience with a once-monthly dosing regimen

These mechanisms make GLP-1RAs highly effective for metabolic disorders, benefiting patients who require both glycemic control and weight reduction

doi: 10.1111/jcmm.12689 [DOI] [PMC free article] [PubMed] [Google Scholar] 50.Nagashima M, Watanabe T, Terasaki M, et al